September 30, 2013Journal of Medical EconomicsOpen Access

Characterizing the financial burden of pulmonary arterial hypertension within an integrated healthcare delivery system

View Full Paper

Ask AI

Bookmark

Population

157 patients with confirmed diagnosis of pulmonary arterial hypertension in Kaiser Permanente Colorado…

Design

Cohort

Follow-up

up to 3 years

Authors

SJSamuel G. JohnsonUniversity of Alaska Fairbanks TDThomas DelateKaiser Permanente ABAdrian BokaDenver Health Medical Center

Discussion

Member takes

Implication

PAH care is linked to high expenditures irrespective of onset; leaves open targeted cost-reduction strategies in real-world data.

Structured PICO

Population

157 patients with confirmed diagnosis of pulmonary arterial hypertension (PAH) in Kaiser Permanente Colorado, including 44 prevalent and 113 incident cases. 55% WHO Group 1 PAH.

Outcome

3-year healthcare expenditures (total per patient per day and 3-year total)

PAH is associated with substantial healthcare expenditures, driven significantly by specialty medications, with median 3-year costs exceeding $50,000 per patient.

Cite This Study

Johnson et al. (2013) studied this question.

synapsesocial.com/papers/6a704f12f44fa9f079dde877 https://doi.org/10.3111/13696998.2013.849713

View Full Paper

Ask AI

Bookmark

September 30, 2013Journal of Medical EconomicsOpen Access

Characterizing the financial burden of pulmonary arterial hypertension within an integrated healthcare delivery system

View Full Paper

Ask AI

Bookmark

Population

157 patients with confirmed diagnosis of pulmonary arterial hypertension in Kaiser Permanente Colorado…

Design

Cohort

Follow-up

up to 3 years

Authors

SJSamuel G. JohnsonUniversity of Alaska Fairbanks TDThomas DelateKaiser Permanente ABAdrian BokaDenver Health Medical Center

Discussion

Member takes

Implication

PAH care is linked to high expenditures irrespective of onset; leaves open targeted cost-reduction strategies in real-world data.

Structured PICO

Population

157 patients with confirmed diagnosis of pulmonary arterial hypertension (PAH) in Kaiser Permanente Colorado, including 44 prevalent and 113 incident cases. 55% WHO Group 1 PAH.

Outcome

3-year healthcare expenditures (total per patient per day and 3-year total)

PAH is associated with substantial healthcare expenditures, driven significantly by specialty medications, with median 3-year costs exceeding $50,000 per patient.

Cite This Study

Johnson et al. (2013) studied this question.

synapsesocial.com/papers/6a704f12f44fa9f079dde877 https://doi.org/10.3111/13696998.2013.849713

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark